Buy the #2 Biotech Stock for Its New DNA Tech (and Profits)

Pacific Biosciences of California Inc. (NASDAQ: PACB) is a biotechnology company that designs, develops, and commercializes a variety of tools for biological research.

Specifically, the company develops next generation DNA-sequencing systems to assist in resolving complex genetical problems.

PacBio’s DNA-sequence systems provide access to a wide range of applications that are designed to improve the accuracy and preciseness of the human, animal, and plant DNAs they test.

The company’s latest sequencing system, known as the “Sequel II,” was released in October 2020 and runs an application called “SMRT Link,” which can assemble genomes with 99.999% accuracy.

finviz dynamic chart for  PACB

As you can tell from the chart above, PACB was trading for $10.50 at the beginning of October 2020.

Since then, it has rocketed 321% higher to $44.20 per share.

That could very well have something to do with the earnings Sequel II is bringing in…

PacBio went from losing $84.1 million in fiscal 2019 to profiting $29.4 million in 2020.

In fact, last year was the company’s first full year with a profit.

And with a full year of the Sequel II in 2021, investors can reasonably expect those profits to continue…

If profits increase, Cathie Wood will likely keep PACB as a core holding in ARKG for the foreseeable future.

The #1 Biotech Stock of 2021 (New Report)

Sponsored

Jeff Brown is arguably America’s #1 most accurate technology investor.

In 2015, he singled out Bitcoin before it shot up almost 100x…

He also recommended the #1 tech investments of 2016, 2018, 2019, and 2020!

Recently, Mr. Brown sat down with Chris Hurt to discuss the state of the stock market…

And discuss his new #1 pick.

As you’ll see, it’s in an industry that billionaires like

Jeff Bezos and Warren Buffett are flocking to it…

(In fact, Buffett recently dumped $800 million of Apple stock to invest in this!)

It’s also set to grow an astonishing 5,900%.

If you have any interest in tech stocks, you can’t miss this special interview. And the new report Jeff Brown put together.

You can click here for the special interview.

P.S. As you’ll see, there is some urgency with Mr. Brown’s #1 pick… His top company is set to release a revolutionary new product as early as March 1st, which could send the stock soaring.

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works